ClinicalTrials.gg
CompletedNCT03480204Updated Feb 19, 2019

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

An observational study in Cardiac Arrhythmia, sponsored by The Cleveland Clinic. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-02-19.

Sponsored by The Cleveland Clinic · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 337 studies in Arrhythmias, Cardiac with a site in United States — 49 open to participants now, 68 under way, none of them phase 3. Arrhythmias, Cardiac · United States.

Enrollment
131st of 154
25 · median 128
Started
2018
with 14 others
Observational
154 of 337
25 open now
Registered
192nd of 337
by date

Among the 337 studies in Arrhythmias, Cardiac with a site in United States, this one is the 131st largest by enrollment of the 154 observational ones that give a count, is one of 15 that started in 2018, is one of 154 observational ones, and was the 192nd registered.

Arrhythmias, Cardiac

1,052 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.

Browse Arrhythmias, Cardiac studies →

Open to participants now

49 of the 337 studies in Arrhythmias, Cardiac with a site in United States are open now. Recruiting first, the newest first:

44 more — sign in →

All 49 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 166 Arrhythmias, Cardiac studies recruiting now, 118 (71%) set no upper age limit and 13 (8%) stop at 75 or younger; 31 take children under 18; 26 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 337 studies in Arrhythmias, Cardiac with a site in United States, or all of them as a file.
02

Study summary

This study evaluates the feasibility and usability of a wearable patch as a cardiac monitor for non-ICU hospitalized patients.

Read the detailed description

This study evaluates the feasibility and usability of a wearable patch cardiac monitor, gateway and server concomitant with standard-of-care cardiac telemetry monitoring for non-ICU hospitalized patients on a selected nursing ward at the Cleveland Clinic Heart and Vascular Institute. All patients will receive routine clinical care on the basis of the traditional telemetry monitoring using the usual processes. The patch monitor data will not be reviewed in real-time, and only analyzed post hoc for agreement with the standard-of-care.

03

Conditions studied

  • Cardiac Arrhythmia

Keywords

  • Telemetry, Patch Monitor, Alarm Fatigue
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Non-ICU hospitalized patients on the J8-3 nursing ward at the Cleveland Clinic Heart and Vascular Institute

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >= 18 years old and able to provide
  • Standard indication for cardiac telemetry monitoring (institutional standardized criteria) with valid electronic order

Exclusion criteria

Exclusion Criteria:

  • Cardiac implantable device (pacemaker or ICD)
  • Contact precautions or isolation
  • Telemetry discontinuation planned within 12 hours (i.e. anticipated discharge)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Connectivity

    Successful patch application by nursing, and transmission of cardiac waveform data to gateway and then to offline secure server

    Time frame: 48 hours

  2. Continuity

    Loss of cardiac waveform signal from patch compared with traditional telemetry monitor.

    Time frame: 48 hours

Secondary outcomes

  1. Agreement for cardiac arrhythmia detection (post hoc, offline)

    Analysis of cardiac arrhythmia detections on patch compared with traditional telemetry for agreement, concordance and discordance.

    Time frame: 48 hours

  2. Body temperature (post hoc, offline)

    Body temperature recorded by patch compared with nursing documentation in a post hoc analysis. Data from patch will not be assessed for patient care in real time.

    Time frame: 48 hours

  3. Cardiac waveform (post hoc, offline)

    Pre-specified analysis of cardiac waveform characteristics in association with pre-specified clinical events such as deployment of emergency response team.

    Time frame: 48 hours

07

Study locations

1 site
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2018 to primary completion in Dec 2018, 9 months.

Of 190 non-industry observational studies under Arrhythmias, Cardiac, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 140. This study's 9 months is below that.

Counting every sponsor, half of 259 studies reached it within 38 months; a quarter within 16 and three quarters within 97.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2018
First posted
Mar 29, 2018
StartActual
Mar 19, 2018
Primary completionActual
Dec 23, 2018
CompletionActual
Dec 23, 2018
Last update
Feb 19, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03480204
Collaborators
Isansys Lifecare LTD
Responsible party
Dan Cantillon (Principal Investigator, The Cleveland Clinic) — Principal investigator
First posted
Mar 29, 2018
Start date
Mar 19, 2018
Primary completion
Dec 23, 2018
Completion
Dec 23, 2018
Last update
Feb 19, 2019

Study contacts

Daniel J Cantillon, MD
principal investigator · The Cleveland Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion